Prescription Drug Sunitinib Malate Subject to Label Mix-Up Recall
AvKARE is recalling 40 bottles of Sunitinib Malate Capsules due to a label mix-up. The affected lot was distributed nationwide in the United States.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This recall meets the rubric criterion for 'risk-of-harm products where injury has not yet been reported'—a prescription drug with a labeling mix-up presents potential for patient harm, though no illnesses or injuries are explicitly reported in the source.
Plain-English summary
AvKARE is recalling 40 bottles of Sunitinib Malate Capsules, 12.5 mg, due to a labeling mix-up. The recall affects Lot #100049371 with an expiration date of July 31, 2026, identified by NDC 42291-901-28.
The affected bottles were distributed nationwide within the United States.
Patients currently taking this medication should contact their healthcare provider or pharmacist for guidance. Healthcare providers and pharmacists should identify and quarantine affected stock from Lot #100049371 and verify that patients have received correct medication.
The recalled product
- Product
- SUNITINIB MALATE (SUNITINIB MALATE)
- Brand
- SUNITINIB MALATE
- Manufacturer
- AvKARE
- Category
- Drug
- Hazard
- label-mix-up
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 100049371
- Exp. Date 07/31/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · SUNITINIB MALATE
- HighSunitinib Malate Capsules Recalled Due to Label Mix-Up
FDA (Drugs) · 2024-12-11
- HighSunitinib Malate Capsules Recalled Due to Excess Moisture Content
FDA (Drugs) · 2023-07-19
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27